Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × Cetuximab × Clear all

NCT00086892 2014-02-14

Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms